论文部分内容阅读
目的:评价精准肝切除治疗原发性肝癌的疗效。方法:选取我院2012年1月-2012年12月间收治的80例原发性肝癌患者,根据手术方式的不同分为观察组和对照组,每组患者各40例。观察组给予精准肝切除治疗,对照组给予常规肝切除治疗,比较两组的手术时间、术中出血量、住院时间、并发症发生率、手术前后肝功能指标、局部复发转移率、2年存活率。结果:在术中出血量、住院时间、并发症发生率方面比较,观察组明显优于对照组,P<0.05具有显著性差异,有统计学意义;与术前比较,术后两组肝功能指标均明显改善,但观察组改善更明显,P<0.05具有显著性差异,有统计学意义;术后随访2年,在局部复发转移率、2年存活率方面比较,观察组明显优于对照组,P<0.05具有显著性差异,有统计学意义。结论:精准肝切除治疗原发性肝癌的疗效显著,值得推广应用。
Objective: To evaluate the efficacy of precise hepatectomy in the treatment of primary liver cancer. METHODS: Eighty patients with primary liver cancer who were admitted to our hospital from January 2012 to December 2012 were selected and divided into observation group and control group according to the different surgical methods. Each group had 40 patients. The observation group was given precise hepatectomy, and the control group was given conventional hepatectomy. The operation time, intraoperative blood loss, length of hospital stay, complication rate, liver function index before and after surgery, local recurrence and metastasis rate, and 2 years survival were compared between the two groups. rate. RESULTS: Compared with the control group, the observation group was significantly better than the control group in terms of blood loss, length of hospital stay, and incidence of complications. P<0.05 had statistically significant difference; compared with preoperative, postoperative liver function The indicators improved significantly, but the observation group improved more significantly, P<0.05 had a significant difference, with statistical significance; after 2 years of follow-up, compared with local recurrence metastasis rate and 2-year survival rate, the observation group was significantly better than the control group. In the group, P<0.05 had a significant difference and was statistically significant. Conclusion: The effect of precise hepatectomy on primary liver cancer is significant and worthy of popularization and application.